A detailed history of Lazard Asset Management LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 107 shares of TSVT stock, worth $319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107
Previous 397 73.05%
Holding current value
$319
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.85 - $5.05 $1,116 - $1,464
-290 Reduced 73.05%
107 $0
Q2 2024

Aug 14, 2024

SELL
$3.6 - $5.79 $25,567 - $41,120
-7,102 Reduced 94.71%
397 $1,000
Q1 2024

May 14, 2024

SELL
$3.09 - $6.0 $11,488 - $22,308
-3,718 Reduced 33.15%
7,499 $39,000
Q4 2023

Feb 14, 2024

BUY
$1.57 - $4.58 $9,286 - $27,090
5,915 Added 111.56%
11,217 $47,000
Q3 2023

Nov 14, 2023

BUY
$3.14 - $11.2 $709 - $2,531
226 Added 4.45%
5,302 $20,000
Q2 2023

Aug 14, 2023

BUY
$8.45 - $12.48 $295 - $436
35 Added 0.69%
5,076 $51,000
Q1 2023

May 15, 2023

SELL
$9.21 - $14.98 $61,946 - $100,755
-6,726 Reduced 57.16%
5,041 $50,000
Q4 2022

Feb 14, 2023

BUY
$8.57 - $17.0 $26,249 - $52,071
3,063 Added 35.19%
11,767 $110,000
Q3 2022

Nov 14, 2022

BUY
$12.56 - $17.54 $94,137 - $131,462
7,495 Added 619.93%
8,704 $126,000
Q2 2022

Aug 09, 2022

BUY
$10.55 - $18.81 $559 - $996
53 Added 4.58%
1,209 $15,000
Q1 2022

May 13, 2022

BUY
$11.67 - $26.72 $3,722 - $8,523
319 Added 38.11%
1,156 $19,000
Q4 2021

Feb 09, 2022

BUY
$13.77 - $42.56 $11,525 - $35,622
837 New
837 $20,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.